Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bradley Sarak

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
JACC. Cardiovascular Imaging|May 5, 2022
Diabetes and Myocardial Fibrosis: Is CMR the Force Leading to the Rise of "Scar Wars"?Kim A Connelly, Bradley Sarak
Journal of Hypertension|November 3, 2017
ReplyBradley Sarak, Ron Wald, Andrew T Yan
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|September 25, 2010
Incidence of very high defibrillation thresholds (DFT) and efficacy of subcutaneous (SQ) array insertion during implantable cardioverter defibrillator (ICD) implantationAtul Verma, Alexander J Kaplan, Bradley Sarak, et al.
Pacing and Clinical Electrophysiology : PACE|October 3, 2009
Predictors of appropriate implantable cardioverter defibrillator (ICD) therapy in primary prevention patients with ischemic and nonischemic cardiomyopathyAtul Verma, Bradley Sarak, Alexander J Kaplan, et al.
Pacing and Clinical Electrophysiology : PACE|September 4, 2013
Myocardial injury secondary to ICD shocks: insights from patients with lead fractureRaed Abu Sham'a, Pablo Nery, Mouhannad Sadek, et al.
Circulation. Cardiovascular Quality and Outcomes|April 5, 2021
Lipid Testing, Lipid-Modifying Therapy, and PCSK9 (Proprotein Convertase Subtilisin-Kexin Type 9) Inhibitor Eligibility in 27 979 Patients With Incident Acute Coronary SyndromeBradley Sarak, Anamaria Savu, Padma Kaul, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|October 13, 2009
Dofetilide is safe and effective in preventing atrial fibrillation recurrences in patients accepted for catheter ablationYana Shamiss, Yaariv Khaykin, Richard Oosthuizen, et al.
JACC. Case Reports|April 4, 2025
Percutaneous Closure of Postinfarct Left Ventricular Pseudoaneurysm After Surgical Patch DehiscenceBryan P Traynor, Syed M Ali Hassan, Thomas Attumalil, et al.
Heart (British Cardiac Society)|November 4, 2009
Incidence of left ventricular function improvement after primary prevention ICD implantation for non-ischaemic dilated cardiomyopathy: a multicentre experienceAtul Verma, Zaev Wulffhart, Dhanunjaya Lakkireddy, et al.
Journal of Hypertension|March 21, 2017
Relationship between changes in blood pressure and left ventricular mass over 1 year in end-stage renal diseaseBradley Sarak, Ron Wald, Marc B Goldstein, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
JACC. Cardiovascular Imaging|May 5, 2022
Diabetes and Myocardial Fibrosis: Is CMR the Force Leading to the Rise of "Scar Wars"?Kim A Connelly, Bradley Sarak
Journal of Hypertension|November 3, 2017
ReplyBradley Sarak, Ron Wald, Andrew T Yan
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|September 25, 2010
Incidence of very high defibrillation thresholds (DFT) and efficacy of subcutaneous (SQ) array insertion during implantable cardioverter defibrillator (ICD) implantationAtul Verma, Alexander J Kaplan, Bradley Sarak, et al.
Pacing and Clinical Electrophysiology : PACE|October 3, 2009
Predictors of appropriate implantable cardioverter defibrillator (ICD) therapy in primary prevention patients with ischemic and nonischemic cardiomyopathyAtul Verma, Bradley Sarak, Alexander J Kaplan, et al.
Pacing and Clinical Electrophysiology : PACE|September 4, 2013
Myocardial injury secondary to ICD shocks: insights from patients with lead fractureRaed Abu Sham'a, Pablo Nery, Mouhannad Sadek, et al.
Circulation. Cardiovascular Quality and Outcomes|April 5, 2021
Lipid Testing, Lipid-Modifying Therapy, and PCSK9 (Proprotein Convertase Subtilisin-Kexin Type 9) Inhibitor Eligibility in 27 979 Patients With Incident Acute Coronary SyndromeBradley Sarak, Anamaria Savu, Padma Kaul, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|October 13, 2009
Dofetilide is safe and effective in preventing atrial fibrillation recurrences in patients accepted for catheter ablationYana Shamiss, Yaariv Khaykin, Richard Oosthuizen, et al.
JACC. Case Reports|April 4, 2025
Percutaneous Closure of Postinfarct Left Ventricular Pseudoaneurysm After Surgical Patch DehiscenceBryan P Traynor, Syed M Ali Hassan, Thomas Attumalil, et al.
Heart (British Cardiac Society)|November 4, 2009
Incidence of left ventricular function improvement after primary prevention ICD implantation for non-ischaemic dilated cardiomyopathy: a multicentre experienceAtul Verma, Zaev Wulffhart, Dhanunjaya Lakkireddy, et al.
Journal of Hypertension|March 21, 2017
Relationship between changes in blood pressure and left ventricular mass over 1 year in end-stage renal diseaseBradley Sarak, Ron Wald, Marc B Goldstein, et al.
Pageof 2